Y1767C, a novel SCN5A mutation, induces a persistent Na+ current and potentiates ranolazine inhibition of Nav1.5 channels
Michael O'Leary
Part of the Pharmacology, Toxicology and Environmental Health Commons
Part of the Pharmacology, Toxicology and Environmental Health Commons